HIV/AIDS TreatmentAdult & Pediatric Similarities and Differences
Global Health Mini-University
October 5, 2007
Objectives
Define Antiretroviral (ARV) Treatment Understand underlying precepts to multi-drug ARV treatment Name the different classes of ARV medications Identify challenges in resource poor settings Differences between adult and pediatric ARV treatment
Approach
Retrovirus Lifecycle of HIV Target points in lifecycle Classes of medications Challenges of a public health approach Special challenges facing children
Human Immunodeficiency Virus
A retrovirus
Life cycle
Fusion
Reverse transcriptase
Protease
Life cycle
Main classes of ARVs
1. 2.
3.
4.
Fusion Inhibitors Nucleoside/tide Reverse Transcriptase Inhibitors (NRTIs and NtRTIs) Non Nucleside Reverse Transcriptase Inhibitors (NNRTI) Protease Inhibitors (PIs)
Fusion Inhibitors
NRTIs
NNRTIs
PIs
Multiple Drug Approach
Adult Resource Poor Settings
http://www.who.int/hiv/pub/guidelines/WHO%20Adult%20ART%20Guidelines.pdf
Pediatric Resource Poor Settings
http://www.who.int/hiv/pub/guidelines/WHOpaediatric.pdf
Public Health Approach
Challenges: Human Resources
Infrastructure
Supplies
Transport
Pediatric Challenges
Diagnosis
< 18 months
Persistence of maternal antibody No EIA, Western Blot Tests for viral components:
HIV DNA or RNA PCR, Immune Complex Dissociated (ICD) p24 antigen Dried Blood Spots (DBS)
> 18 months
Can use EIA, Western Blot
Natural Progression of HIV in Children
If undiagnosed/untreated:
mortality by 1 year 50% mortality by age 2 60% mortality by age 3
35%
WHO World Health Report 2005
Signs & Symptoms
Often non-specific
Respiratory distress Poor weight gain weight or abnormal growth Missed milestones in development
crawling, walking and speaking
Poor school performance, seizures, and other symptoms of HIV encephalopathy
Challenges
Pediatric expertise and experience Misperceptions that all infected children will die early in childhood Caretaker dependence Drug availability, appropriate formulations at affordable prices
http://www.who.int/3by5/en/finalreport.pdf
Children and ARV Medications
Delivery
Liquid v. solid Whole, split, crushed, dispensed in water With or without food Multiple times per day Fixed Dose Combinations (FDC)
Children and ARV Medications
Taste
Palatable?
Dosage
Growth Pharmacokinetics Mg/kg, mg/m2 (BSA), weight bands
From Abrams, El-Sadr and Rabkin: The ICAP Pediatric Clinical Manual, September 2004
Children and ARV Medications
Other
Cold chain storage Toxicities Adverse reactions Dependence on a caretaker
Objectives
Define Antiretroviral (ARV) Treatment Understand underlying precepts to multi-drug ARV treatment Name the different classes of ARV medications Identify challenges in resource poor settings Differences between adult and pediatric ARV treatment Similarities/Differences
Discussion
• • • • • www.usaid.gov www.pepfar.gov www.globalhealthlearning.org http://depts.washington.edu/hivaids/index.html www.who.int/hiv/pub/guidelines/en/
sammyc2007 4/17/2008 |
10 |
0 |
0 |
educational
sammyc2007 4/25/2008 |
23 |
0 |
0 |
educational
sammyc2007 4/15/2008 |
51 |
1 |
0 |
educational
sammyc2007 4/15/2008 |
35 |
1 |
0 |
educational
sammyc2007 4/17/2008 |
82 |
1 |
0 |
educational
sammyc2007 4/24/2008 |
32 |
0 |
0 |
educational
sammyc2007 4/25/2008 |
75 |
2 |
0 |
educational
sammyc2007 4/25/2008 |
53 |
1 |
0 |
educational
sammyc2007 4/23/2008 |
148 |
8 |
0 |
educational
sammyc2007 4/17/2008 |
18 |
0 |
0 |
educational
sammyc2007 4/16/2008 |
22 |
0 |
0 |
educational
sammyc2007 4/16/2008 |
67 |
2 |
0 |
educational
sammyc2007 4/17/2008 |
21 |
0 |
0 |
educational
sammyc2007 4/25/2008 |
24 |
0 |
0 |
educational
sammyc2007 4/25/2008 |
35 |
1 |
0 |
educational
sammyc2007 6/13/2008 |
113 |
4 |
0 |
legal
sammyc2007 6/13/2008 |
92 |
0 |
0 |
legal
sammyc2007 6/13/2008 |
145 |
4 |
0 |
legal
sammyc2007 6/13/2008 |
133 |
2 |
0 |
legal
sammyc2007 6/13/2008 |
248 |
1 |
0 |
legal
sammyc2007 6/13/2008 |
183 |
0 |
0 |
legal
sammyc2007 6/13/2008 |
104 |
0 |
0 |
legal
sammyc2007 6/13/2008 |
78 |
0 |
0 |
legal
sammyc2007 6/13/2008 |
200 |
0 |
0 |
legal
sammyc2007 6/13/2008 |
129 |
0 |
0 |
legal